| 國家衛生研究院 |
2004-09 |
Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: A preliminary study
|
Wang, J; Chen, LT; Tsang, YM; Liu, TW; Shih, TTF |
| 臺大學術典藏 |
2004 |
Dynamic contrast-enhanced MRI analysis of perfusion changes in advanced hepatocellular carcinoma treated with an antiangiogenic agent: A preliminary study
|
TIFFANY TING-FANG SHIH; Liu T.-W.; Tsang Y.-M.; Chen L.-T.; Wang J.; Wang J.;Chen L.-T.;Tsang Y.-M.;Liu T.-W.;Tiffany Ting-Fang Shih |
| 臺北醫學大學 |
2005 |
Dynamic Contrast-enhanced MRI Assessment of Patellar Perfusion in ACL-resected Model for Early Chondromalacia Patellae Perfusion in Rabbits: Preliminary Report.
|
陳榮邦; Chan WP; Kuo TF; Huang GS; Wu YL; Lin MF; Liu YJ |
| 國立臺灣大學 |
2012 |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強 |
| 臺大學術典藏 |
2018-09-10T09:15:12Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang, Yeun-Chung; Yu, Chong-Jen; Chen, Chung-Ming; Hu, Fu-Chang; Hsu, Hao-Hsiang; Tseng, Wen-Yih I.; Shih, Tiffany Ting-Fang; Yang, Pan-Chyr; Yang, James Chih-Hsin曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強; 曾文毅; 楊志新; 陳中明; 張允中; 施庭芳; 楊泮池; 余忠仁; 胡賦強Chang, Y.-C.; Yu, C.-J.; Chen, C.-M.; Hu, F.-C.; Hsu, H.-H.; Tseng, W.-Y.I.; Ting-Fang Shih, T.; Yang, P.-C.; Chih-Hsin Yang, J.; 楊泮池; Chang, Yeun-Chung; TIFFANY TING-FANG SHIH; Yu, Chong-Jen; Chen, Chung-Ming; CHONG-JEN YU; Yang, Pan-Chyr |
| 臺大學術典藏 |
2012 |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; TIFFANY TING-FANG SHIH; Yang P.-C.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-05-26T09:27:05Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chih-Hsin Yang;Yang P.-C;Ting-Fang Shih T;Tseng W.-Y.I;Hsu H.-H;Hu F.-C;Chen C.-M;Yu C.-J;Chang Y.-C; Chang Y.-C; Yu C.-J; Chen C.-M; Hu F.-C; Hsu H.-H; Tseng W.-Y.I; Ting-Fang Shih T; Yang P.-C; Chih-Hsin CHIH-HSIN YANG |
| 臺大學術典藏 |
2020-12-02T02:33:57Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; Pan-Chyr Yang; Chih-Hsin Yang J.; Chang Y.-C.; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; PAN-CHYR YANG; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2021-03-19T06:57:41Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
YEUN-CHUNG CHANG; Yu C.-J.; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; Yang P.-C.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2022-06-27T07:02:05Z |
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatin
|
Chang Y.-C.; CHONG-JEN YU; Chen C.-M.; Hu F.-C.; Hsu H.-H.; Tseng W.-Y.I.; Ting-Fang Shih T.; Yang P.-C.; Chih-Hsin Yang J. |
